Description

Lumenis VersaPulse PowerSuite 100W Holmium laser

Versatile Solutions for Stone Lithotripsy including Stone-Dusting

The VersaPulse laser enables a wide range of settings from stone fragmentation to Stone- Dusting. Stone-Dusting Lithotripsy at high-frequency of above 50Hz is efficient at pulverizing stones. Clinical evidence suggests that stone dusting may reduce the need for basket extraction thereby decreasing possible complications associated with the routine use of ureteral access sheaths8.
The low energy per pulse applied in dusting typically minimizes retropulsion.
FEATURES Lumenis VersaPulse PowerSuite 100W

Avoid access operation time
Low reoperation rates, as mentioned in the AUA guidelines for BPH
Wide patient applicability
Compared with alternative treatment options for BPH, HoLEP has a major advantage in efficacy and safety

Product Details Lumenis VersaPulse PowerSuite 100W

100W Holmium Laser
Designed to be used for high-power applications such as holmium laser ablation of the prostate (HoLAP) and bladder stone fragmentation.

80/100W Holmium Laser
Combines two wavelengths – 80 Watts Holmium and 100 Watts Nd:YAG lasers which is ideal for procedures requiring high-energy and strong coagulation capabilities.

60W Holmium Laser
A versatile mid-power laser, capable of handling a wide range of applications requiring precise cutting and controlled ablation including stones, tumors and strictures.

20W Holmium Laser
A compact and versatile laser providing optimal power for effective stone and soft tissue treatments.

VersaPulse PowerSuite 100W
100W Holmium Laser For High-Power Applications

The VersaPulse PowerSuite 100W was Lumenis’ first high-watt holmium laser solution and a pioneer in its field. It has a successful clinical track record of over 15 years in treatment prostate enucleation (HoLEP) and stone lithotripsy.
Pioneer in HoLEP Procedures

The VersaPulse PowerSuite clinical outcomes are documented in dozens of peer reviewed articles for over a decade and are shown to:

Avoid access operation time
Low reoperation rates, as mentioned in the AUA guidelines for BPH
Wide patient applicability
Compared with alternative treatment options for BPH, HoLEP has a major advantage in efficacy and safety